slides · global inventory
Gantt Chart
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,118
Current window 601-630
Pages 38
Rows per page 30
Framework
601-630 of 1,118
22
The slide uses a split-column layout to track two separate product development timelines.Arrival | Results Presentation Deck | 42 slides · Arrival
Conference presentation Investor relations Beat · Action1 hit
06
The slide uses a Gantt-style visualization to represent the clinical development status of multiple drug candidates.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
17
The slide uses a timeline diagram to illustrate the clinical trial flow and two boxes to detail study design and operational status.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
17
The slide uses a horizontal timeline structure to map specific drug programs (BEN-2293, BEN-8744, etc.) against time-based milestones.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
03
Berkeley Lights | Investor Day Presentation Deck | 91 slidesBerkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · Attention1 hit
73
The slide uses a timeline visual combined with a comparison table to show product evolution.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
07
The slide uses a Gantt-style visualization to show the clinical stage of drug candidates.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
31
The slide uses a timeline-based visualization to show dose escalation steps. RP2D = Recommended Phase 2 Dose. DLT = Dose Limiting Toxicity.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 1 hit
35
The slide uses a table-based timeline format to map specific clinical trial phases to programs and indications.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 1 hit
08
The slide uses a horizontal bar chart format to represent clinical trial stages for various assets.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
48
The slide outlines a development roadmap with specific milestones and associated funding amounts.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
08
The slide uses a Gantt-style visualization to show progress of drug candidates.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
37
The slide uses a process-oriented layout to categorize projects into 'Therapeutic Vaccine Platform' and 'Platform Expansion'.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Why Now1 hit
05
The slide uses a Gantt-style visualization to show the progress of different drug candidates.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style chart to visualize the progress of drug candidates through discovery, preclinical, and clinical phases.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
09
The chart uses a horizontal bar format to represent clinical trial stages for different medical conditions.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
16
The slide outlines a 42-day study timeline with a 28-day treatment period.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
23
The slide outlines a randomized clinical trial structure with a 1:1:1:1 ratio, a 12-month treatment period, and a 1-month follow-up.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
26
The slide outlines a randomized clinical trial structure with three dosing arms and a follow-up period.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
09
The slide uses a Gantt-style chart to map drug programs against development stages.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
30
Uses checkmarks for completed items and circular arrows for upcoming/potential items.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style visualization to map drug development stages against specific clinical indications and future catalysts.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
07
NASH (Non-Alcoholic Steatohepatitis); IND (Investigational New Drug); MAD (Multiple Ascending Dose); SAD (Single Ascending Dose).NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
24
The slide uses a Gantt-style timeline to represent drug development stages.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Beat · Market Size1 hit
19
The slide uses a Gantt-style bar chart to represent the clinical stage of each program.OmniAb | Investor Conference Presentation Deck | 27 slides · OmniAb
Conference presentation Investor relations Loop · Why Now1 hit
03
The slide uses a custom pipeline visualization that maps candidates to specific indications and next milestones.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · Problem1 hit
06
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
18
The slide outlines a randomized, placebo-controlled trial structure with specific weeks and days for allergen challenges and measurements.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations 1 hit
19
The slide uses a timeline-based visualization to show clinical progress and pairs it with financial status.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · The Ask1 hit
26
The slide uses checkmarks for completed items and empty squares for future items.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit